Location History:
- Tuebingen, DE (2008 - 2012)
- Tubingen, DE (1998 - 2017)
Company Filing History:
4 out of 16 
2 out of 16 
1 out of 6,662 
Years Active: 1998-2017
Title: **Innovations by Hans-Jorg Buhring in Mesenchymal Stem Cell Research**
Introduction
Hans-Jorg Buhring is a prominent inventor based in Tubingen, Germany, known for his significant contributions to the field of stem cell research. With an impressive portfolio of 10 patents, he has been at the forefront of developing innovative methods for the isolation and identification of mesenchymal stem cells (MSCs).
Latest Patents
One of Hans-Jorg Buhring's latest patents involves the MSC surface marker, which focuses on the use of antibodies that bind to the SUSD2 antigen. This invention includes a combination of antibodies that interact with CD140b, CD56, and/or TNAP, aimed at isolating mesenchymal stem cells with exceptional chondrocytic and osteogenic differentiation potential. The patent further outlines processes for efficiently isolating these stem cells using the specified antibodies.
Another significant patent from his repertoire is a method for isolating and identifying mesenchymal stem cells, which utilizes antibodies derived from hybridoma cell lines such as W8B2, W1C3, and others. This innovation provides a valuable technique for identifying and isolating homogenous mesenchymal stem cells from adult primary tissues, particularly bone marrow, ensuring a high level of purity in the isolated cells.
Career Highlights
Throughout his career, Hans-Jorg Buhring has worked with esteemed institutions including Eberhard Karls University of Tubingen and Eberhard Karls Universitaet Tuebingen Universitaetsklinikum. His dedication to research and innovation in the field of stem cells has made him a key figure in advancing medical science.
Collaborations
Hans-Jorg Buhring has collaborated with notable colleagues such as Reiner Lammers and Gunther Jung. These partnerships have contributed to the success of his research projects and the advancement of methodologies in stem cell isolation and identification.
Conclusion
Hans-Jorg Buhring's work exemplifies the impact of innovative research in the field of mesenchymal stem cells. His extensive patents and collaborations highlight his commitment to enhancing our understanding of stem cells and their potential applications in medicine. His contributions are poised to pave the way for future advancements in regenerative medicine and beyond.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.